This week’s episode features a fascinating conversation with Samin Saeed, UK Chief Scientific Officer and Medical Director at Novartis UK. She discusses a whole host of medical affairs-related issues, including the transition from medicine to pharma, cross-functionality, commercial versus medical affairs, and lots more besides, including a fascinating discussion about leadership, company culture and soft skills development. And ‘news you might have missed’ focuses on the European life sciences gender pay gap and new investment for Novartis.
If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:
Preparing MSLs for the spotlight https://www.emg-gold.com/post/preparing-msls-for-the-spotlight
Juby Jacob-Nara on medical affairs https://www.emg-gold.com/post/juby-jacob-nara-on-medical-affairs
Aliya Omer on gender equality https://www.emg-gold.com/post/podcast-aliya-omer-on-gender-equality
Reframing pharma’s bad boy reputation https://www.emg-gold.com/post/reframing-pharma-s-bad-boy-reputation
Elevating pharma’s parental leave policies https://www.emg-gold.com/post/elevating-pharma-s-parental-leave-policies
